CARDIOVASCULAR RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$87,491,417
Investments
28%
Cash & Equivalents
24%
Other Assets
21%
Receivables (Non-Related)
15%
Property, Plant, & Equipment (net)
9%
Prepaid Expenses
3%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$37,248,809
Other Liabilities
47%
Tax-Exempt Bond Liabilities
26%
Payables & Accruals
22%
Deferred Revenue
6%
Grants Payable
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$28,367,512
$21,382,536
-25%
Receivables (Non-Related)
$15,485,969
$13,076,045
-16%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$2,306,356
$2,512,825
+9%
Investments
$16,136,145
$24,387,580
+51%
Property, Plant, & Equipment (net)
$8,225,464
$7,899,066
-4%
Other Assets
$21,448,438
$18,233,365
-15%
Total Assets
$91,969,884
$87,491,417
-5%
Liabilities
2023
2024
Change
Payables & Accruals
$13,079,582
$8,185,232
-37%
Grants Payable
-
-
-
Deferred Revenue
$2,489,270
$2,057,939
-17%
Tax-Exempt Bond Liabilities
$10,510,001
$9,600,000
-9%
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$19,465,317
$17,405,638
-11%
Total Liabilities
$45,544,170
$37,248,809
-18%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$46,425,714
$50,242,608
+8%
Net assets
2023
2024
Change
Net assets
+$46,425,714
+$50,242,608
+8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)